Today: 30 April 2026
Seagate stock slips as insider sales surface and tech rout drags on
5 February 2026
1 min read

Seagate stock slips as insider sales surface and tech rout drags on

New York, February 5, 2026, 11:43 ET — Regular session

Shares of Seagate Technology Holdings plc (STX) dropped roughly 1.9% to $410.82 in late-morning action Thursday, after bouncing between $424.89 and $394.85. Western Digital (WDC) and NetApp (NTAP) also slipped, with the Nasdaq-tracking QQQ and the S&P 500’s SPY each off about 1%.

The tech selloff dragged down yet another AI-related hardware stock amid broader market losses. Global equities dropped again Thursday, with investors fretting over the rising costs tied to the AI surge and waning risk appetite.

Wall Street’s mood has soured on valuations and the staying power of the AI rally. “The market is suddenly skeptical and concerned about it,” said Jed Ellerbroek, portfolio manager at Argent Capital in St. Louis, in a Reuters interview Wednesday. Reuters

Analysts are holding firm. Cantor Fitzgerald boosted its price target for Seagate to $650 from $500 on Wednesday, maintaining an “overweight” rating that points to anticipated gains. BNP Paribas followed suit and raised its target as well, according to MT Newswires. MarketScreener

New insider trading disclosures caught investors’ attention. According to a Form 4 filing, CEO William Mosley offloaded 20,000 ordinary shares on Feb. 2. Prices ranged between $401.10 and $434.31. The filing noted these sales occurred under a Rule 10b5-1 plan, a prearranged program allowing executives to sell shares on a set timetable.

A separate Form 4 filing revealed that EVP and Chief Commercial Officer Ban Seng Teh exercised 9,433 options and sold 20,195 shares on Jan. 29, with prices ranging from $440 to $444. After the transactions, he holds 3,092 ordinary shares.

Seagate’s latest quarterly report, out late last month, showed revenue hitting $2.83 billion with adjusted earnings per share at $3.11. The company projects fiscal third-quarter revenue around $2.90 billion, give or take $100 million. Mosley noted the December-quarter numbers “exceeded our expectations” and highlighted the “durability of data center demand.” Seagate Investors

Reuters noted the outlook surpassed analyst forecasts, boosting the belief that demand from data-center expansions is driving storage suppliers higher. The company’s shares have more than tripled in 2025, the report said, making it vulnerable to sharper drops during tech sell-offs.

Volatility was evident in trading this week. On Wednesday, chipmakers and AI-infrastructure firms took a hit following a disappointing forecast from Advanced Micro Devices. Seagate’s shares dropped over 6%, according to Nasdaq.com.

The storage trade could just as easily reverse. If cloud spending slows or pricing power slips, the earnings narrative would come under immediate pressure. Plus, insider selling during a rally tends to raise caution among some investors.

Traders remain focused on whether the recent spate of upgrades and insider activity will settle down or continue to stoke volatility as Seagate’s next quarterly report approaches. MarketScreener has it penciled in for April 28.

Stock Market Today

  • Biogen Shares Rise 6% After Q1 Earnings Beat Despite Guidance Cut
    April 29, 2026, 9:29 PM EDT. Biogen (NASDAQ: BIIB) shares rose 6% on Wednesday following its first-quarter 2026 earnings report. The biotech posted $2.48 billion in revenue, surpassing analyst expectations of $2.25 billion. Net income, excluding accounting standards (GAAP), increased 19% to over $529 million, or $3.57 per share, above forecasts of $2.95. Growth was driven by strong sales of Leqembi, for early Alzheimer's, up 74%, and the FDA-approved Skyclarys for Friedreich's ataxia. However, Biogen cut full-year adjusted net income guidance by $1 per share citing research and development charges. Revenue is expected to decline mid-single digits from 2025, excluding a pending $5.6 billion acquisition of Apellis Pharmaceuticals. Biogen's strategic shift towards high-potential therapies is underway despite cautious outlook.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Broadcom stock rises as Google flags up to $185 billion in AI capex spending
Previous Story

Broadcom stock rises as Google flags up to $185 billion in AI capex spending

Applied Materials (AMAT) stock snaps back near $300 as Alphabet AI spend stirs chip-equipment trade
Next Story

Applied Materials (AMAT) stock snaps back near $300 as Alphabet AI spend stirs chip-equipment trade

Go toTop